Silver Book Fact

An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.

Toth C, Mawani S, Brady S, Chan C, et al. An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain. Pain. 2012; 153(10): 2073-82. http://journals.lww.com/pain/Abstract/2012/10000/An_enriched_enrolment,_randomized_withdrawal,.16.aspx

Reference

Title
An Enriched-Enrollment, Randomized Withdrawal, Flexible-Dose, Double-Blind, Placebo-Controlled, Parallel Assignment Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain
Publication
Pain
Publication Date
2012
Authors
Toth C, Mawani S, Brady S, Chan C, et al
Volume & Issue
Volume 153, Issue 10
Pages
2073-82
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.  
  • Brain imaging is showing that pain changes the structure and function of brain regions that perceive pain, making it persistent. These brain networks and receptor targets are being identified…  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.